Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2025-12-25 @ 8:19 PM
NCT ID: NCT01336569
Description: This reporting group includes all participants who received study product.
Frequency Threshold: 5
Time Frame: Adverse events were collected for the duration of the study.
Study: NCT01336569
Study Brief: Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
DuoTrav Travoprost 0.004%/timolol maleate 0.5% fixed combination, one drop to the study eye nightly for up to 6 weeks None None 1 49 0 49 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Enterorrhagia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Other Events(If Any):